Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro)

NCT02945176 is registered in ClinicalTrials.gov with Implandata Ophthalmic Products GmbH as lead sponsor.

NCT NCT02945176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro)
Lead sponsor
Implandata Ophthalmic Products GmbH
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
June 14, 2017
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemical burns, congenital aniridia, congenital glaucoma, graft vs host disease, stevens-johnson syndrome